HomeAKUMS • NSE
add
Akums Drugs and Pharmaceuticals Ltd
Previous close
₹618.25
Day range
₹595.25 - ₹627.25
Year range
₹530.05 - ₹1,175.90
Market cap
92.78B INR
Avg Volume
412.12K
P/E ratio
33.18
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 10.33B | -12.54% |
Operating expense | 3.51B | 6.42% |
Net income | 652.06M | 104.98% |
Net profit margin | 6.31 | 134.57% |
Earnings per share | — | — |
EBITDA | 1.21B | -31.74% |
Effective tax rate | 27.23% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.95B | 222.58% |
Total assets | 42.70B | 18.47% |
Total liabilities | 14.23B | -53.12% |
Total equity | 28.47B | — |
Shares outstanding | 149.21M | — |
Price to book | 3.26 | — |
Return on assets | — | — |
Return on capital | 9.26% | — |
Cash Flow
Net change in cash
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 652.06M | 104.98% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2004
Website
Employees
7,388